Grete Waitz, Legendary Marathon Runner and Cancer Activist, Dies At 57

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

The legendary Norwegian marathon runner Grete Waitz died last night. She ran her first New York City marathon as an unknown at age 25, not only winning the race but shattering the world record by a full two minutes. She went on to win a total of nine New York City marathons, a record that has not been matched by any other runner. I had the great privilege of seeing her cross the finish line on many of those wins. Waitz was known for her dignity, decency, and grace, and has served as an inspiration for generations of runners. She is considered by many to be one of the greatest athletes of the century.

Waitz had been battling cancer for many years. When discussing her fitness level and how it has enhanced her ability to fight the disease, she is quoted as saying, “I am convinced you can go through a lot more when you are physically fit. It is both physical and mental. With the athletic background, you think more on the positive side — you can do this.” Running the race in 1992, in what she considered her “tenth victory,” she crossed the finish line hand-in-hand with Fred Lebow, the founder of the New York City Marathon. He was battling brain cancer at the time. Waitz created a cancer foundation called Aktiv Mot Kreft (Active Against Cancer), which among other things sponsors runners in major races. Waitz believed that physical activity could prevent cancer and improve quality of life for those afflicted with the disease.

Click here for coverage and photos in the New York Times.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter